LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea · Delayed Price · Currency is KRW 134,600
+100 (0.07%)
Jun 19, 2026, 3:30 PM KST
LigaChem Biosciences Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, LigaChem Biosciences stock has a consensus rating of "Buy" and an average price target of ₩224,286. The average 1-year stock price forecast is 66.63% higher than the current stock price, while the lowest is ₩200,000 (+48.59%) and the highest is ₩240,000 (+78.31%).
Price Target: ₩224,286 (+66.63%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LigaChem Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 3 | 2 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 5 | 6 | 7 |
Financial Forecast
Revenue This Year
218.74B
from 141.55B
Increased by 54.53%
Revenue Next Year
260.34B
from 218.74B
Increased by 19.02%
EPS This Year
-1.49K
from -2.04K
EPS Next Year
885.72
from -1.49K
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 283.1B | ||
| Avg | 218.7B | ||
| Low | 173.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 100.0% | ||
| Avg | 54.5% | ||
| Low | 22.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 723.09 | ||
| Avg | -1,488.87 | ||
| Low | -2,738.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |